382 related articles for article (PubMed ID: 20956339)
1. TIM-3: a novel regulatory molecule of alloimmune activation.
Boenisch O; D'Addio F; Watanabe T; Elyaman W; Magee CN; Yeung MY; Padera RF; Rodig SJ; Murayama T; Tanaka K; Yuan X; Ueno T; Jurisch A; Mfarrej B; Akiba H; Yagita H; Najafian N
J Immunol; 2010 Nov; 185(10):5806-19. PubMed ID: 20956339
[TBL] [Abstract][Full Text] [Related]
2. The amelioration of composite tissue allograft rejection by TIM-3-modified dendritic cell: Regulation of the balance of regulatory and effector T cells.
Wang Y; Zheng Z; Zhu X; Han J; Dong M; Tao K; Wang H; Wang Y; Hu D
Immunol Lett; 2016 Jan; 169():15-22. PubMed ID: 26561949
[TBL] [Abstract][Full Text] [Related]
3. Suppression of allograft rejection by Tim-1-Fc through cross-linking with a novel Tim-1 binding partner on T cells.
Xiao L; Fu ZR; Liu F; Zhang LD; Shi XM; Shen XY; Ni ZJ; Fu H; Li RD; Cao XT; Ding GS; Wang QX
PLoS One; 2011; 6(7):e21697. PubMed ID: 21750723
[TBL] [Abstract][Full Text] [Related]
4. The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.
Ju Y; Shang X; Liu Z; Zhang J; Li Y; Shen Y; Liu Y; Liu C; Liu B; Xu L; Wang Y; Zhang B; Zou J
Mol Immunol; 2014 Mar; 58(1):85-91. PubMed ID: 24333756
[TBL] [Abstract][Full Text] [Related]
5. The emerging role of T cell Ig mucin 1 in alloimmune responses in an experimental mouse transplant model.
Ueno T; Habicht A; Clarkson MR; Albin MJ; Yamaura K; Boenisch O; Popoola J; Wang Y; Yagita H; Akiba H; Ansari MJ; Yang J; Turka LA; Rothstein DM; Padera RF; Najafian N; Sayegh MH
J Clin Invest; 2008 Feb; 118(2):742-51. PubMed ID: 18172549
[TBL] [Abstract][Full Text] [Related]
6. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells.
Matesic D; Valujskikh A; Pearlman E; Higgins AW; Gilliam AC; Heeger PS
J Immunol; 1998 Nov; 161(10):5236-44. PubMed ID: 9820495
[TBL] [Abstract][Full Text] [Related]
7. Adoptive Transfer of Tracer-Alloreactive CD4
Miller ML; Chen J; Daniels MD; McKeague MG; Wang Y; Yin D; Vu V; Chong AS; Alegre ML
Am J Transplant; 2016 Oct; 16(10):2842-2853. PubMed ID: 27063351
[TBL] [Abstract][Full Text] [Related]
8. The role of the ICOS-B7h T cell costimulatory pathway in transplantation immunity.
Harada H; Salama AD; Sho M; Izawa A; Sandner SE; Ito T; Akiba H; Yagita H; Sharpe AH; Freeman GJ; Sayegh MH
J Clin Invest; 2003 Jul; 112(2):234-43. PubMed ID: 12865411
[TBL] [Abstract][Full Text] [Related]
9. Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs.
Gupta S; Thornley TB; Gao W; Larocca R; Turka LA; Kuchroo VK; Strom TB
J Clin Invest; 2012 Jul; 122(7):2395-404. PubMed ID: 22684103
[TBL] [Abstract][Full Text] [Related]
10. A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy.
Yuan X; Paez-Cortez J; Schmitt-Knosalla I; D'Addio F; Mfarrej B; Donnarumma M; Habicht A; Clarkson MR; Iacomini J; Glimcher LH; Sayegh MH; Ansari MJ
J Exp Med; 2008 Dec; 205(13):3133-44. PubMed ID: 19047438
[TBL] [Abstract][Full Text] [Related]
11. Tim-1 blockade with RMT1-10 increases T regulatory cells and prolongs the survival of high-risk corneal allografts in mice.
Tan X; Jie Y; Zhang Y; Qin Y; Xu Q; Pan Z
Exp Eye Res; 2014 May; 122():86-93. PubMed ID: 24613782
[TBL] [Abstract][Full Text] [Related]
12. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
Kim EY; Lee EN; Lee J; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Joh JW; Kim SJ
Exp Mol Med; 2006 Jun; 38(3):284-94. PubMed ID: 16819287
[TBL] [Abstract][Full Text] [Related]
13. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
[TBL] [Abstract][Full Text] [Related]
14. NK cells are required for costimulatory blockade induced tolerance to vascularized allografts.
van der Touw W; Burrell B; Lal G; Bromberg JS
Transplantation; 2012 Sep; 94(6):575-84. PubMed ID: 22914174
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
[TBL] [Abstract][Full Text] [Related]
16. Relative Frequencies of Alloantigen-Specific Helper CD4 T Cells and B Cells Determine Mode of Antibody-Mediated Allograft Rejection.
Alsughayyir J; Chhabra M; Qureshi MS; Mallik M; Ali JM; Gamper I; Moseley EL; Peacock S; Kosmoliaptsis V; Goddard MJ; Linterman MA; Motallebzadeh R; Pettigrew GJ
Front Immunol; 2018; 9():3039. PubMed ID: 30740108
[TBL] [Abstract][Full Text] [Related]
17. Preferential involvement of Tim-3 in the regulation of hepatic CD8+ T cells in murine acute graft-versus-host disease.
Oikawa T; Kamimura Y; Akiba H; Yagita H; Okumura K; Takahashi H; Zeniya M; Tajiri H; Azuma M
J Immunol; 2006 Oct; 177(7):4281-7. PubMed ID: 16982862
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of tolerance induced by donor-specific transfusion and ICOS-B7h blockade in a model of CD4+ T-cell-mediated allograft rejection.
Sandner SE; Clarkson MR; Salama AD; Sanchez-Fueyo A; Yagita H; Turka LA; Sayegh MH
Am J Transplant; 2005 Jan; 5(1):31-9. PubMed ID: 15636609
[TBL] [Abstract][Full Text] [Related]
19. Involvement of T cell Ig Mucin-3 (Tim-3) in the negative regulation of inflammatory bowel disease.
Li X; Chen G; Li Y; Wang R; Wang L; Lin Z; Gao X; Feng J; Ma Y; Shen B; Li Y; Han G
Clin Immunol; 2010 Feb; 134(2):169-77. PubMed ID: 19913460
[TBL] [Abstract][Full Text] [Related]
20. Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells.
Wang F; Wan L; Zhang C; Zheng X; Li J; Chen ZK
Immunobiology; 2009; 214(5):342-9. PubMed ID: 19362679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
